<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35328353</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>23</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
              <Day>08</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effect of Trehalose and Ceftriaxone on the Stability of Aggregating-Prone Tau Peptide Containing PHF6* Sequence: An SRCD Study.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">2932</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23062932</ELocationID>
        <Abstract>
          <AbstractText>The tau protein, a soluble protein associated with microtubules, which is involved in the assembly and stabilization of cytoskeletal elements, was found to form neurofibrillary tangles in different neurodegenerative diseases. Insoluble tau aggregates were observed to be organized in paired helical filaments (PHFs) and straight filaments (SFs). Recently, two small sequences (306-311 and 275-280) in the microtubule-binding region (MTBR), named PHF6 and PHF6*, respectively, were found to be essential for tau aggregation. Since a possible therapeutic approach consists of impairing amyloid formation either by stabilizing the native proteins or reducing the level of amyloid precursors, here we use synchrotron radiation circular dichroism (SRCD) at Diamond B23 beamline to evaluate the inhibitory effects of two small molecules, trehalose and ceftriaxone, against the aggregation of a small peptide containing the PHF6* sequence. Our results indicate that both these molecules, ceftriaxone and trehalose, increased the stability of the peptide toward aggregation, in particular that induced by heparin. With trehalose being present in many fruits, vegetables, algae and processed foods, these results support the need to investigate whether a diet richer in trehalose might exert a protective effect toward pathologies linked to protein misfolding.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Honisch</LastName>
            <ForeName>Claudia</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0001-9720-6176</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Biomolecular Chemistry of CNR, Padua Unit, Via Marzolo 1, 35131 Padova, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Chemical Sciences, University of Padua, Via Marzolo 1, 35131 Padova, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Torni</LastName>
            <ForeName>Federica</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biomolecular Chemistry of CNR, Padua Unit, Via Marzolo 1, 35131 Padova, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hussain</LastName>
            <ForeName>Rohanah</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0001-6207-6631</Identifier>
            <AffiliationInfo>
              <Affiliation>Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, Oxfordshire OX11 0DE, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ruzza</LastName>
            <ForeName>Paolo</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0002-5596-9295</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Biomolecular Chemistry of CNR, Padua Unit, Via Marzolo 1, 35131 Padova, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Siligardi</LastName>
            <ForeName>Giuliano</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0002-4667-6423</Identifier>
            <AffiliationInfo>
              <Affiliation>Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, Oxfordshire OX11 0DE, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C502542">PHF6 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012097">Repressor Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>75J73V1629</RegistryNumber>
          <NameOfSubstance UI="D002443">Ceftriaxone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>B8WCK70T7I</RegistryNumber>
          <NameOfSubstance UI="D014199">Trehalose</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002443" MajorTopicYN="N">Ceftriaxone</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002942" MajorTopicYN="N">Circular Dichroism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016874" MajorTopicYN="N">Neurofibrillary Tangles</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012097" MajorTopicYN="N">Repressor Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017356" MajorTopicYN="N">Synchrotrons</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014199" MajorTopicYN="N">Trehalose</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016875" MajorTopicYN="Y">tau Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ceftriaxone</Keyword>
        <Keyword MajorTopicYN="N">conformational stability</Keyword>
        <Keyword MajorTopicYN="N">intrinsically disordered proteins</Keyword>
        <Keyword MajorTopicYN="N">protein aggregation</Keyword>
        <Keyword MajorTopicYN="N">synchrotron radiation circular dichroism</Keyword>
        <Keyword MajorTopicYN="N">tau protein</Keyword>
        <Keyword MajorTopicYN="N">tauopathies</Keyword>
        <Keyword MajorTopicYN="N">transmission electron microscopy</Keyword>
        <Keyword MajorTopicYN="N">trehalose</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>25</Day>
          <Hour>1</Hour>
          <Minute>6</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35328353</ArticleId>
        <ArticleId IdType="pmc">PMC8951053</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms23062932</ArticleId>
        <ArticleId IdType="pii">ijms23062932</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Uversky V.N., Kulkarni P. Intrinsically disordered proteins: Chronology of a discovery. Biophys. Chem. 2021;279:106694. doi: 10.1016/j.bpc.2021.106694.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bpc.2021.106694</ArticleId>
            <ArticleId IdType="pubmed">34607199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monti S.M., De Simone G., Langella E. The Amazing World of IDPs in Human Diseases. Biomolecules. 2021;11:333.  doi: 10.3390/biom11020333.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/biom11020333</ArticleId>
            <ArticleId IdType="pmc">PMC7926885</ArticleId>
            <ArticleId IdType="pubmed">33672116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo T., Noble W., Hanger D.P. Roles of tau protein in health and disease. Acta Neuropathol. 2017;133:665–704. doi: 10.1007/s00401-017-1707-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-017-1707-9</ArticleId>
            <ArticleId IdType="pmc">PMC5390006</ArticleId>
            <ArticleId IdType="pubmed">28386764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orr M.E., Sullivan A.C., Frost B. A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies. Trends Pharmacol. Sci. 2017;38:637–648. doi: 10.1016/j.tips.2017.03.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tips.2017.03.011</ArticleId>
            <ArticleId IdType="pmc">PMC5476494</ArticleId>
            <ArticleId IdType="pubmed">28455089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mamun A.A., Uddin M.S., Mathew B., Ashraf G.M. Toxic tau: Structural origins of tau aggregation in Alzheimer’s disease. Neural Regen. Res. 2020;15:1417–1420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7059584</ArticleId>
            <ArticleId IdType="pubmed">31997800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skrabana R., Sevcik J., Novak M. Intrinsically disordered proteins in the neurodegenerative processes: Formation of tau protein paired helical filaments and their analysis. Cell Mol. Neurobiol. 2006;26:1085–1097. doi: 10.1007/s10571-006-9083-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10571-006-9083-3</ArticleId>
            <ArticleId IdType="pubmed">16779670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Almeida Z.L., Brito R.M.M. Structure and Aggregation Mechanisms in Amyloids. Molecules. 2020;25:1195.  doi: 10.3390/molecules25051195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules25051195</ArticleId>
            <ArticleId IdType="pmc">PMC7179426</ArticleId>
            <ArticleId IdType="pubmed">32155822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mukrasch M.D., Biernat J., von Bergen M., Griesinger C., Mandelkow E., Zweckstetter M. Sites of Tau Important for Aggregation Populate β-Structure and Bind to Microtubules and Polyanions. J. Biol. Chem. 2005;280:24978–24986. doi: 10.1074/jbc.M501565200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M501565200</ArticleId>
            <ArticleId IdType="pubmed">15855160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bachmann S., Bell M., Klimek J., Zempel H. Differential Effects of the Six Human TAU Isoforms: Somatic Retention of 2N-TAU and Increased Microtubule Number Induced by 4R-TAU. Front. Neurosci. 2021;15:547. doi: 10.3389/fnins.2021.643115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2021.643115</ArticleId>
            <ArticleId IdType="pmc">PMC8185039</ArticleId>
            <ArticleId IdType="pubmed">34113229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smit F.X., Luiken J.A., Bolhuis P.G. Primary Fibril Nucleation of Aggregation Prone Tau Fragments PHF6 and PHF6*. J. Phys. Chem. B. 2017;121:3250–3261. doi: 10.1021/acs.jpcb.6b07045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.jpcb.6b07045</ArticleId>
            <ArticleId IdType="pubmed">27776213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li W., Lee V.M.Y. Characterization of Two VQIXXK Motifs for Tau Fibrillization in Vitro. Biochemistry. 2006;45:15692–15701. doi: 10.1021/bi061422+.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/bi061422+</ArticleId>
            <ArticleId IdType="pubmed">17176091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Combs B., Voss K., Gamblin T.C. Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms. Biochemistry. 2011;50:9446–9456. doi: 10.1021/bi2010569.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/bi2010569</ArticleId>
            <ArticleId IdType="pmc">PMC3224825</ArticleId>
            <ArticleId IdType="pubmed">21942206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Von Bergen M., Barghorn S., Li L., Marx A., Biernat J., Mandelkow E.M., Mandelkow E. Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J. Biol. Chem. 2001;276:48165–48174. doi: 10.1074/jbc.M105196200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M105196200</ArticleId>
            <ArticleId IdType="pubmed">11606569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levine Z.A., Larini L., LaPointe N.E., Feinstein S.C., Shea J.-E. Regulation and aggregation of intrinsically disordered peptides. Proc. Natl. Acad. Sci. USA. 2015;112:2758–2763. doi: 10.1073/pnas.1418155112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1418155112</ArticleId>
            <ArticleId IdType="pmc">PMC4352815</ArticleId>
            <ArticleId IdType="pubmed">25691742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larini L., Gessel M.M., LaPointe N.E., Do T.D., Bowers M.T., Feinstein S.C., Shea J.-E. Initiation of assembly of tau (273–284) and its ΔK280 mutant: An experimental and computational study. Phys. Chem. Chem. Phys. 2013;15:8916–8928. doi: 10.1039/c3cp00063j.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/c3cp00063j</ArticleId>
            <ArticleId IdType="pmc">PMC3663921</ArticleId>
            <ArticleId IdType="pubmed">23515417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lorente-Gea L., García B., Martín C., Ordiales H., García-Suárez O., Piña-Batista K.M., Merayo-Lloves J., Quirós L.M., Fernández-Vega I. Heparan Sulfate Proteoglycans Undergo Differential Expression Alterations in Alzheimer Disease Brains. J. Neuropathol. Exp. Neurol. 2020;79:474–483. doi: 10.1093/jnen/nlaa016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jnen/nlaa016</ArticleId>
            <ArticleId IdType="pubmed">32232475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holmes B.B., DeVos S.L., Kfoury N., Li M., Jacks R., Yanamandra K., Ouidja M.O., Brodsky F.M., Marasa J., Bagchi D.P., et al.  Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc. Natl. Acad. Sci. USA. 2013;110:E3138–E3147. doi: 10.1073/pnas.1301440110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1301440110</ArticleId>
            <ArticleId IdType="pmc">PMC3746848</ArticleId>
            <ArticleId IdType="pubmed">23898162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruzza P.  Small Molecules that Ameliorate Protein Misfolding. In: Atta-ur-Rahman F., editor. Advances in Organic Synthesis. Volume 7. Bentham Science Publishers; Sharjah, United Arab Emirates: 2017. pp. 3–30.</Citation>
        </Reference>
        <Reference>
          <Citation>Marchiani A., Mammi S., Siligardi G., Hussain R., Tessari I., Bubacco L., Delogu G., Fabbri D., Dettori M.A., Sanna D., et al.  Small molecules interacting with α-synuclein: Antiaggregating and cytoprotective properties. Amino Acids. 2013;45:327–338. doi: 10.1007/s00726-013-1503-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00726-013-1503-3</ArticleId>
            <ArticleId IdType="pubmed">23645386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honisch C., Hussain R., Siligardi G., Ruzza P. Influence of small molecules on the photo-stability of water soluble porcine lens proteins. Chirality. 2020;32:611–618. doi: 10.1002/chir.23210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/chir.23210</ArticleId>
            <ArticleId IdType="pubmed">32114715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruzza P., Hussain R., Biondi B., Calderan A., Tessari I., Bubacco L., Siligardi G. Effects of Trehalose on Thermodynamic Properties of Alpha-synuclein Revealed through Synchrotron Radiation Circular Dichroism. Biomolecules. 2015;5:724–734. doi: 10.3390/biom5020724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/biom5020724</ArticleId>
            <ArticleId IdType="pmc">PMC4496693</ArticleId>
            <ArticleId IdType="pubmed">25946077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruzza P., Siligardi G., Hussain R., Marchiani A., Islami M., Bubacco L., Delogu G., Fabbri D., Dettori M.A., Sechi M., et al.  Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitro. ACS Chem. Neurosci. 2014;5:30–38. doi: 10.1021/cn400149k.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/cn400149k</ArticleId>
            <ArticleId IdType="pmc">PMC3894726</ArticleId>
            <ArticleId IdType="pubmed">24099687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruzza P., Vitale R.M., Hussain R., Montini A., Honisch C., Pozzebon A., Hughes C.S., Biondi B., Amodeo P., Sechi G., et al.  Chaperone-like effect of ceftriaxone on HEWL aggregation: A spectroscopic and computational study. Biochim. Biophys. Acta Gen. Sub. 2018;1862:1317–1326. doi: 10.1016/j.bbagen.2018.02.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbagen.2018.02.014</ArticleId>
            <ArticleId IdType="pubmed">29524538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruzza P., Vitale R.M., Hussain R., Biondi B., Amodeo P., Sechi G., Siligardi G. Interactions of GFAP with ceftriaxone and phenytoin: SRCD and molecular docking and dynamic simulation. Biochim. Biophys. Acta. 2016;1860:2239–2248. doi: 10.1016/j.bbagen.2016.04.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbagen.2016.04.021</ArticleId>
            <ArticleId IdType="pubmed">27133445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sechi G., Matta M., Deiana G.A., Balbi P., Bachetti T., Di Zanni E., Ceccherini I., Serra A. Ceftriaxone has a therapeutic role in Alexander disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2010;34:416–417. doi: 10.1016/j.pnpbp.2009.11.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pnpbp.2009.11.021</ArticleId>
            <ArticleId IdType="pubmed">19948199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leung T.C.H., Lui C.N.P., Chen L.W., Yung W.H., Chan Y.S., Yung K.K.L. Ceftriaxone Ameliorates Motor Deficits and Protects Dopaminergic Neurons in 6-Hydroxydopamine-Lesioned Rats. ACS Chem. Neurosci. 2012;3:22–30. doi: 10.1021/cn200072h.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/cn200072h</ArticleId>
            <ArticleId IdType="pmc">PMC3369786</ArticleId>
            <ArticleId IdType="pubmed">22860178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain N.K., Roy I. Effect of trehalose on protein structure. Protein Sci. 2009;18:24–36. doi: 10.1002/pro.3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pro.3</ArticleId>
            <ArticleId IdType="pmc">PMC2708026</ArticleId>
            <ArticleId IdType="pubmed">19177348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luyckx J., Baudouin C. Trehalose: An intriguing disaccharide with potential for medical application in ophthalmology. Clin. Ophthalmol. 2011;5:577–581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3102588</ArticleId>
            <ArticleId IdType="pubmed">21654884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siddhanta S., Barman I., Narayana C. Revealing the trehalose mediated inhibition of protein aggregation through lysozyme-silver nanoparticle interaction. Soft Matter. 2015;11:7241–7249. doi: 10.1039/C5SM01896J.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/C5SM01896J</ArticleId>
            <ArticleId IdType="pubmed">26271458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chemes L.B., Alonso L.G., Noval M.G., de Prat-Gay G. Circular dichroism techniques for the analysis of intrinsically disordered proteins and domains. Methods Mol. Biol. 2012;895:387–404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22760329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen S., Yin H., Zhang L., Liu R., Qi W., He Z., Su R. Oligomeric procyanidins inhibit insulin fibrillation by forming unstructured and off-pathway aggregates. RSC Adv. 2021;11:37290–37298. doi: 10.1039/D1RA05397C.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/D1RA05397C</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Micsonai A., Wien F., Bulyáki É., Kun J., Moussong É., Lee Y.-H., Goto Y., Réfrégiers M., Kardos J. BeStSel: A web server for accurate protein secondary structure prediction and fold recognition from the circular dichroism spectra. Nucleic Acids Res. 2018;46:W315–W322. doi: 10.1093/nar/gky497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gky497</ArticleId>
            <ArticleId IdType="pmc">PMC6031044</ArticleId>
            <ArticleId IdType="pubmed">29893907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Micsonai A., Wien F., Kernya L., Lee Y.H., Goto Y., Réfrégiers M., Kardos J. Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy. Proc. Natl. Acad. Sci. USA. 2015;112:E3095–E3103. doi: 10.1073/pnas.1500851112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1500851112</ArticleId>
            <ArticleId IdType="pmc">PMC4475991</ArticleId>
            <ArticleId IdType="pubmed">26038575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hussain R., Benning K., Myatt D., Javorfi T., Longo E., Rudd T.R., Pulford B., Siligardi G. CDApps: Integrated software for experimental planning and data processing at beamline B23, Diamond Light Source. J. Synchrotron Radiat. 2015;22:862. doi: 10.1107/S1600577515007602.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1107/S1600577515007602</ArticleId>
            <ArticleId IdType="pmc">PMC4416693</ArticleId>
            <ArticleId IdType="pubmed">25931108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mandelkow E., von Bergen M., Biernat J., Mandelkow E.M. Structural principles of tau and the paired helical filaments of Alzheimer’s disease. Brain Pathol. 2007;17:83–90. doi: 10.1111/j.1750-3639.2007.00053.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1750-3639.2007.00053.x</ArticleId>
            <ArticleId IdType="pmc">PMC8095506</ArticleId>
            <ArticleId IdType="pubmed">17493042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahanger I.A., Parray Z.A., Nasreen K., Ahmad F., Hassan M.I., Islam A., Sharma A. Heparin Accelerates the Protein Aggregation via the Downhill Polymerization Mechanism: Multi-Spectroscopic Studies to Delineate the Implications on Proteinopathies. ACS Omega. 2021;6:2328–2339. doi: 10.1021/acsomega.0c05638.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acsomega.0c05638</ArticleId>
            <ArticleId IdType="pmc">PMC7841943</ArticleId>
            <ArticleId IdType="pubmed">33521471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Behrendt R., White P., Offer J. Advances in Fmoc solid-phase peptide synthesis. J. Pept. Sci. Off. Publ. Eur. Pept. Soc. 2016;22:4–27. doi: 10.1002/psc.2836.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/psc.2836</ArticleId>
            <ArticleId IdType="pmc">PMC4745034</ArticleId>
            <ArticleId IdType="pubmed">26785684</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
